@Davisite Is the process that helped give RC220 its new dissolubility transferable to other drugs that have had other precipitation and phlebitis issues? Have RAC and their collaborators stumbled onto another potential income stream?
- Forums
- ASX - By Stock
- RAC
- Ann: RC220 Peripheral Infusion Safety Confirmed
Ann: RC220 Peripheral Infusion Safety Confirmed, page-25
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.68 |
Change
-0.070(4.01%) |
Mkt cap ! $285.2M |
Open | High | Low | Value | Volume |
$1.78 | $1.78 | $1.68 | $146.3K | 85.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7 | $1.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 4796 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 5856 | 1.675 |
1 | 1000 | 1.670 |
1 | 1000 | 1.665 |
2 | 8165 | 1.660 |
4 | 7600 | 1.650 |
Price($) | Vol. | No. |
---|---|---|
1.685 | 1000 | 1 |
1.690 | 14047 | 2 |
1.695 | 422 | 2 |
1.700 | 3562 | 2 |
1.705 | 2638 | 3 |
Last trade - 14.15pm 03/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online